These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10902861)

  • 1. Assessment of iron absorption from ferric trimaltol.
    Reffitt DM; Burden TJ; Seed PT; Wood J; Thompson RP; Powell JJ
    Ann Clin Biochem; 2000 Jul; 37 ( Pt 4)():457-66. PubMed ID: 10902861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron.
    Harvey RS; Reffitt DM; Doig LA; Meenan J; Ellis RD; Thompson RP; Powell JJ
    Aliment Pharmacol Ther; 1998 Sep; 12(9):845-8. PubMed ID: 9768526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
    Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.
    Kontoghiorghes GJ; Kolnagou A; Demetriou T; Neocleous M; Kontoghiorghe CN
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test.
    Kelsey SM; Hider RC; Bloor JR; Blake DR; Gutteridge CN; Newland AC
    J Clin Pharm Ther; 1991 Apr; 16(2):117-22. PubMed ID: 1856249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
    Gasche C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Büning C; Howaldt S; Stallmach A;
    Inflamm Bowel Dis; 2015 Mar; 21(3):579-88. PubMed ID: 25545376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.
    Schmidt C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Howaldt S; Stallmach A; Büning C;
    Aliment Pharmacol Ther; 2016 Aug; 44(3):259-70. PubMed ID: 27237709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
    Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
    Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.
    Barrand MA; Callingham BA
    Br J Pharmacol; 1991 Feb; 102(2):408-14. PubMed ID: 2015422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of reductive mechanisms for intestinal uptake of iron from ferric maltol and ferric nitrilotriacetic acid (NTA).
    Barrand MA; Hider RC; Callingham BA
    J Pharm Pharmacol; 1990 Apr; 42(4):279-82. PubMed ID: 1974298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron absorption following a single oral dose of ferrous sulfate or ferric gluconate in patients with gastrectomy.
    Santarpia L; Pagano MC; Cuomo R; Alfonsi L; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2013; 63(1-2):55-9. PubMed ID: 23899667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat.
    Barrand MA; Callingham BA; Dobbin P; Hider RC
    Br J Pharmacol; 1991 Mar; 102(3):723-9. PubMed ID: 1364845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
    Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron-sucrose formulations.
    Goggin MM; Gozum SD; Burrows DM; Nguyen A; Corcoran HF; Dotzauer H; Tann CM; Lundberg RA; Janis GC
    Bioanalysis; 2011 Aug; 3(16):1837-46. PubMed ID: 21877893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F; Löhr B; Laubender RP; Tillack C; Schnitzler F; Breiteneicher S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
    Digestion; 2012; 85(1):47-54. PubMed ID: 22179489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are ferric compounds useful in treatment of iron deficiency anemia?
    Arvas A; Gür E
    Turk J Pediatr; 2000; 42(4):352-3. PubMed ID: 11196760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study.
    Potgieter MA; Potgieter JH; Venter C; Venter JL; Geisser P
    Arzneimittelforschung; 2007; 57(6A):376-84. PubMed ID: 17691587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.